Caffeine Citrate 20mg/ml Premixed Injection from Japan
Premixed injectable caffeine citrate (purine alkaloid derivative) for neonatal apnea treatment in measured vials. Therapeutic alkaloid product HTS 3004.49.0060 for retail medical use.
Duty Rate — Japan → United States
15%
Rate breakdown
9903.04.6215%Pharmaceuticals: patented pharma from JP/EU/KR/CH/LI — 15% floor rate
9903.05.860%Universal product exemption (U.S. note 52(b))
9903.05.900%Articles already subject to Section 232 (steel/aluminum/copper + derivatives, autos + parts, wood, medium/heavy vehicles + parts, semiconductors, patented pharma) — U.S. note 52(f)
Import Tips
• Neonatal dosing precision documentation
• pH stability for injections
• Exclude from stimulant beverages per chapter exclusions